Readify

Dr. Chigwell’s notebooks

Blood Shot

Dr. Chigwell’s notebooks are a long-kept record of Xerxes employees that becomes a potential source of corporate exposure and a test of V. I. Warshawski’s resolve. Gustav Humboldt calls the notes inaccurate, yet fears that their appearance in the wrong hands could damage Humboldt Chemical—and that proving them wrong would be difficult.

Origin and Contents

Dr. Chigwell kept notes on employees at the Xerxes plant over a period of years. Humboldt says he learned of the records only recently and insists that their information is useless because it is inaccurate. He also stresses that he did not know about them while they were being kept, attributing this to the difficulty of overseeing every detail of a company as large as Humboldt Chemical.

The notes’ stated subject is the employees, but the evidence does not specify what particular medical information or cases they contain. Their importance lies partly in their duration: Warshawski points out that records accumulated over twenty years would be hard to discredit simply by declaring the data wrong.

A Record That Could Look Damaging

Humboldt distinguishes between the notebooks’ accuracy and their possible effect. Even if their contents are incorrect, he fears that they might look damaging to the company, and that it could be difficult to prove every piece of information false. The notebooks therefore threaten Humboldt Chemical not only through what they may establish, but through the challenge of answering a substantial record compiled over time.

That concern gives the notebooks value in a larger dispute. Humboldt treats their possession as important enough to bargain for, while Warshawski links them to the prospect of lawsuits whose potential scale, she estimates, could reach half a billion dollars. The medical notes are thus no longer merely a private record of employees; they have become material with possible legal and financial consequences.

The Bargaining Attempt

Humboldt tries to secure the notebooks from Warshawski by offering to provide her mortgage and withdraw a threat against Dr. Herschel. He adds compensation for the trouble caused by his overly zealous associates. As a visible inducement, he produces a document representing two thousand preferred shares of Humboldt Chemical. At the previous close of 101 3/8, Warshawski calculates the offer’s value at two hundred thousand dollars, without brokerage fees.

Warshawski registers the offer without accepting its terms. She points out that she could make twice as much by shorting Humboldt if money were her priority, then makes clear that the notebooks are not available: they have already gone to an attorney and a team of medical specialists. She rejects the proposed exchange rather than surrendering records already placed with legal and medical experts.

Custody and Significance

The attempted bargain ends with Humboldt unable to retrieve the notebooks from Warshawski. Their transfer to an attorney and medical specialists changes their role: instead of remaining leverage in a private negotiation, they are positioned for professional review. The evidence does not establish what the experts ultimately conclude, but Humboldt’s fear that the records could support damaging claims—and Warshawski’s estimate of the lawsuits’ possible value—make their examination consequential.

Humboldt frames his offer as a choice between protecting Dr. Herschel, whom he describes as a mother figure to Warshawski, and helping workers she has never met. Warshawski rejects that framing, invoking the notebooks’ existing destination and Dr. Herschel’s reputation for probity; she also insists that Louisa Djiak is not a casual acquaintance. In the scene, the records expose the limits of Humboldt’s assumption that everyone can be pressured or bought: his money and promises cannot reverse their transfer or persuade Warshawski to abandon the people and claims she considers worth defending.

Related StoryFlow